Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823847 · ClinicalTrials.gov registry record · Early Phase 1
Non Invasive Oral Cancer Screening Among HIV Infected Individuals
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
NCT02823847: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02823847 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 44 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823847, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.
Primary Outcome
Positive predictive value defined as the number of true positives (confirmed PMOLs) divided by the total number of suspicious lesions.
Interventions
- BEHAVIORAL Self-Help Materials
- BEHAVIORAL Screening Interview
- DEVICE Carbon Monoxide Test
- PROCEDURE Visual Oral Screening Examination
- PROCEDURE Direct Fluorescent Oral Visualization Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2021-07-26 |
| Phase | Early Phase 1 |
What the finished NCT02823847 record still lists
NCT02823847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 5 interventions - of which Self-Help Materials is the first listed.
NCT02823847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823847 about?
NCT02823847 is a clinical study titled "Non Invasive Oral Cancer Screening Among HIV Infected Individuals". The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.
What is the current status of trial NCT02823847?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2016-06-30. Estimated completion is 2021-07-26.
What interventions are being tested in trial NCT02823847?
The interventions under investigation include: Self-Help Materials (BEHAVIORAL), Screening Interview (BEHAVIORAL), Carbon Monoxide Test (DEVICE), Visual Oral Screening Examination (PROCEDURE), Direct Fluorescent Oral Visualization Examination (PROCEDURE).
Who is sponsoring clinical trial NCT02823847?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02823847's enrollment target sits among peer trials
44 589th of 2000 higher than 1,402 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI